Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 235-237

  Ferreiro, José Luis ^a,b   Gómez Hospital, Joan Antoni ^a   Cequier, Ángel R ^a   Angiolillo, Dominick J ^b   Roura, Gerard ^a   Teruel, Luis ^a   Maristany, Jaume ^a   Gómez Lara, Josep ^a   Jara, Francesc ^a   Bass, Theodore A ^b   Esplugas, Enric ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary revascularization; Impella Recover LP 2.5; Left ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIB;

ABDOMINAL AORTA; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE DISEASE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; FEMALE; HEART ASSIST DEVICE; HIGH RISK PATIENT; HUMAN; LETTER; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

EID: 78650015026     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.08.003     Document Type: Article

References (13)

1. C. Briguori, C. Sarais, P. Pagnotta, F. Airoldi, F. Liistro, and F. Sgura Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty Am Heart J 145 2003 700 707
2. S. Mishra, W.W. Chu, R. Torguson, R. Wolfram, R. Deible, and W.O. Suddath Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention Am J Cardiol 98 2006 608 612
3. G.W. Stone, D. Marsalese, B.R. Brodie, J.J. Griffin, B. Donohue, and C. Costantini A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators J Am Coll Cardiol 29 1997 1459 1467
4. K. Vijayalakshmi, B. Kunadian, V.J. Whittaker, R.A. Wright, J.A. Hall, and A. Sutton Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action J Invasive Cardiol 19 2007 339 346
5. M. Valgimigli, P. Steendijk, G. Sianos, E. Onderwater, and P.W. Serruys Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention Catheter Cardiovasc Interv 65 2005 263 267
6. J.P. Henriques, M. Remmelink, J. Baan Jr, R.J. van der Schaaf, M.M. Vis, and K.T. Koch Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5 Am J Cardiol 97 2006 990 992
7. H. Thiele, P. Sick, E. Boudriot, K.W. Diederich, R. Hambrecht, and J. Niebauer Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock Eur Heart J 26 2005 1276 1283
8. M. Remmelink, K.D. Sjauw, J.P. Henriques, R.J. de Winter, K.T. Koch, and R.J. van der Schaaf Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics Catheter Cardiovasc Interv 70 2007 532 537
9. J.H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L.S. Cohen, and J. Dalen Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76 1987 142 154
10. K. Thygesen, J.S. Alpert, H.D. White, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, A.S. Jaffe, F.S. Apple, and M. Galvani Universal definition of myocardial infarction Circulation 116 22 2007 2634 2653 (Pubitemid 350182388)
11. M. Seyfarth, D. Sibbing, I. Bauer, G. Fröhlich, L. Bott-Flügel, and R. Byrne A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction J Am Coll Cardiol 52 2008 1584 1588
12. S.R. Dixon, J.P. Henriques, L. Mauri, K. Sjauw, A. Civitello, and B. Kar A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience JACC Cardiovasc Interv 2 2009 91 96
13. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150